Expired CME Article

Approach to Communicating with Patients About the Use of Nutritional Supplements in Cancer Care

Authors: Moshe Frenkel, MD, Eran Ben-Arye, MD, Constance D. Baldwin, PHD, Victor Sierpina, MD

Abstract

In recent years, complementary and alternative medicine has become popular among the general population in the Western world. Cancer patients have joined this global trend, often seeking supplements to conventional oncologic care, usually without their physicians’ knowledge. Among the most common forms of complementary and alternative medicine used by cancer patients are natural products such as herbs and megavitamins. The extensive use of nutritional supplements by cancer patients raises multiple questions and challenges for the physician. Since there are limited scientific data on the efficacy and safety of many nutritional supplements, advising patients about when to use them during the course of illness is difficult. This is true for each stage of cancer care: prevention, acute active care (radiation, chemotherapy, surgery), and post-acute care (follow-up visits and prevention of recurrence). The authors describe a patient-centered approach to the use of nutritional supplements in cancer care.


Key Points


* Nutritional supplement use is popular among patients who are concerned about cancer care.


* The extensive use of nutritional supplements by patients with cancer raises multiple questions and challenges for the physician.


* A patient-centered approach to the use of nutritional supplements in cancer care is suggested; this approach makes use of all available scientific data relating to safety and efficacy of these supplements, combined with an open discussion with the patients about their needs and expectations.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Richardson M, Sanders T, Palmer J, et al. Complementary alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505–2514.
 
2. Sparber A, Bauer L, Curt G, et al. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum 2000;17:623–630.
 
3. Sandler S, Halabi S, Kaplan E, et al. Use of vitamins, minerals, and nutritional supplements by participants in a chemoprevention trial. Cancer 2001;91:1040–1045.
 
4. Newman V, Rock C, Faerber S, et al. Dietary supplement use by women at risk for breast cancer recurrence: the women’s healthy eating and living study group. J Am Diet Assoc 1998;98:285–292.
 
5. Von Gruenigen V, White L, Kirven M, et al. A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer 2001;11:205–209.
 
6. Boon H, Stewart M, Kennard M, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 2000;18:2515–2521.
 
7. Paltiel O, Avitzour T, Cherny N, et al. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 2001;19:2439–2444.
 
8. Eisenberg D, Davis R, Ettner S, et al. Trends in Alternative Medicine Use in the United States, 1990–1997: results of a Follow-up National Survey. JAMA 1998;280:1569–1575.
 
9. Katsuya T, Maskarinec G, Shumay D, et al. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psychooncology2002;11:212–220.
 
10. Weiger W, Smith M, Boon H. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002;137:889–903.
 
11. Eliason B, Huebner J, Marchand L. What physicians can learn from consumers of dietary supplements. J Fam Pract 1999;48:459–463.
 
12. Eliason B, Myzkowski J, Marbella A, et al. Use of dietary supplements by patients in a family practice clinic. J Am Board Fam Pract 1996;9:249–253.
 
13. Gotay C, Dumitriu D. Health food store recommendations for breast cancer patients. Arch Fam Med2000;9:692–698.
 
14. Sierpina V. Ethics forum: complementary medicine and cancer care. Am Med News October 4, 2004.
 
15. Ben-Arye E, Frenkel M, Margalit R. Approaching complementary and alternative medicine use in patients with cancer: questions and challenges. J Ambul Care Manage 2004;27:53–62.
 
16. Atkins DS, Shetty P. Update of the evidence from randomized controlled trials, 1999–2002: routine vitamin supplementation to prevent cancer. Agency for Healthcare Research and Quality. Available at:http://www.ahrq.gov/clinic/3rduspstf/vitamins/vitupdate.htm. Accessed on November 11, 2004.
 
17. Guirguis-Blake J. Putting prevention into practice: routine vitamin supplementation to prevent cancer and cardiovascular disease. Am Fam Physician 2004;70:559.
 
18. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999;91:317–331.
 
19. Bushman J. Green tea and cancer in humans: a review of the literature. Nutr Cancer 1998;31:151–159.
 
20. Mukhtar H, Ahmad N. Green tea in chemoprevention of cancer. Toxicol Sci 1999;52(Suppl 2):111–117.
 
21. Sugiyama T, Sadzuka Y. Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer Lett 1998;133:19–26.
 
22. Kucuk O, Sarkar F, Djuric Z, et al. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med 2002;227:881–885.
 
23. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy.Oncology 1999;13:1003–1012.
 
24. Cascinu S, Catalano V, Cordella L, et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2002;20:3478–3483.
 
25. Austin S. Antioxidants and chemotherapy. Health Notes Review 1999;6:234–236.
 
26. Kelly K. The Labriola/Livingston article reviewed. Oncology 1999;13:1008–1011.
 
27. Prasad K, Cole W, Kumar B, et al. Pros and cons of antioxidant use during radiation therapy.Cancer Treatment Rev 2002;28:79–91.
 
28. Inoue M, Tajima K, Mizutani M, et al. Regular consumption of green tea and the risk of breast cancer recurrence: follow up study from the Hospital-Based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett 2001;167:175–182.
 
29. UTMB CAM web site. Available at: http://cam.utmb.edu/default.asp. Accessed August 12, 2004.
 
30. MD Anderson CAM web site. Available at: http://www.mdanderson.org/departments/CIMER/. Accessed August 12, 2004.
 
31. Natural Medicine Comprehensive Database web site (requires subscription). Available at:http://www.naturaldatabase.com/. Accessed August 12, 2004.
 
32. ConsumerLab.Com, LLC. Available at: http://www.consumerlab.com. Accessed August 12, 2004.